APPENDICEAL CANCER

Clinical trials for APPENDICEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new APPENDICEAL CANCER trials appear

Sign up with your email to follow new studies for APPENDICEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New Two-Drug attack targets Tough-to-Treat cancers

Disease control Ongoing

This study is testing a new oral drug, JAB-21822, combined with an existing cancer drug called cetuximab. It is for people with advanced colorectal, small intestine, or appendix cancers that have a specific genetic change called KRAS G12C. The main goals are to find a safe and ef…

Matched conditions: APPENDICEAL CANCER

Phase: PHASE1, PHASE2 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

APPENDICEAL CANCER

Get alerted when new APPENDICEAL CANCER trials appear

New Two-Drug attack targets Tough-to-Treat cancers